Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Beyond Meat, Burcon NutraScience, Nestle - scalable growth with plant proteins

Humanity is always striving for improvement. This has not only been the case since the climate debate, but innovations in all areas of everyday life are constantly changing our lives. The changes will never again be as slow as they are at this moment. Research and development ...

Burcon, Canopy, dynaCERT - how cannabis, proteins and hydrogen improve the world

Innovations continuously change our lives. Entrepreneurs around the globe are trying to make things happen, developing products and technologies that are designed to improve everyday life. Business areas that are scalable are particularly successful. Once a product is ready to...

The ‘Lean Mean Fighting Machine’ That’s Redefining the Cannabis 2.0 Marketplace

The rubber has finally hit the road for Cannabis 2.0. And conventional wisdom says it's the infused beverage market to be the engine that will drive it. Hill Street Beverage Company Inc . ( TSX-V.BEER , OTCQB: HSEEF , Forum ) boasts some of the infused beverage sector&...

Burcon Nutrascience, Enthusiast Gaming, EXMceuticals - Investing in the future

Innovative technologies and social trends often determine the positive performance of an investment portfolio. The biggest challenge, however, is to recognize the development of a new need in society at the right time and to benefit from it with the right companies. But unders...

Burcon, HelloFresh, Memphasys, TUI - winners of the Corona crisis

The past three months have changed the world. Since the outbreak of the Corona Pandemic, the travel business has come to a standstill and the supply of various food products and everyday items has been characterized by bottlenecks. The meat industry is struggling with infectio...

The S&P 500 Signals Cleared Up – And They Lean Bullish

Yes, it has been only yesterday when we talked about the mixed signals stocks were sending out. Given yesterday’s surprise finish to their intraday resiliency, it might seem misplaced to interpret those hints as bullish. Yet, that’s exactly what...

How This Food Investment Company is Making the Plant-based Sector Accessible

Interest in plant-based products is hotter now more than ever, and companies in this sector are busy ramping up their efforts to meet the demand from consumers as the switch to more sustainable lifestyles continues to grow. Eat Well Investment Group Inc. ( CSE:EWG , ...

Building a Better Covid-19 Antibody Test

ProMIS is harnessing its unique technology platform to develop a more error-free antibody test. Testing has been an Achilles heel of the coronavirus pandemic, but ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB) has partnered with Dr. Hans Frykman and the ...

Protalix Shares Trade up 70% Upon Release of Phase 3 Fabry Disease Data

Shares of Protalix Biotherapeutics skyrocketed today on much higher than average volume as the firm announced positive 12-month interim data from its BRIDGE Phase 3 open label switch-over study of pegunigalsidase alfa (PRX-102) for the treatment of Fabry disease. Earl...

MyoKardia Shares Get a Jolt from Positive Phase 3 HCM Clinical Trial Results

Shares of MyoKardia traded 60% higher, setting a new 52-week high price, after the company reported that it met all primary and secondary endpoints in the Phase 3 EXPLORER study of mavacamten in treatment of obstructive hypertrophic cardiomyopathy. Clinical-...
1 2 3 4 5 6 7 8 9